Companies Dominating the Stereotactic Surgery Devices Landscape
- Koninklijke Philips N.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hitachi Medical Systems
- Huiheng Group
- Siemens AG
- Elekta AB
- Varian Medical Systems
- IBA
- Accuray Incorporated
- GE Healthcare
- Toshiba Energy Systems & Solutions Corporation
Browse Key Market Insights with Data Illustration:
In the News
- Siemens AG announced to acquisition of Varian Medical Systems, Inc. to create a highly integrated portfolio of imaging, laboratory diagnostics, and artificial intelligence for the treatment of cancer, and establish a strong and trusted partner capable of supporting customers and patients across the entire cancer care. Furthermore, the acquisition will enable the company to address the growing need for personalized, data-driven diagnosis and precision cancer care and support oncology clinicians and patients in achieving better outcomes.
- Varian Medical Systems, Inc. announced that it has obtained clearance from the FDA for the use of the first linear accelerators TrueBeam and Edge systems that are intended to accurately target tumors and other diseases using radiation. Furthermore, TrueBeam and Edge systems will be used to treat medically refractory essential tremors with stereotactic radiosurgery to improve the lives of many patients who might otherwise be forced to live with untreatable essential tremors.
